FY 2019 REVENUES
REVENUES GROWTH IN FY 2019
ONCOLOGY ORDERS GROWTH IN FY 2019
NON-GAAP EPS 1 GROWTH IN FY 2019
Varian (NYSE: VAR) today announced that Dow Wilson, chief executive officer, and Chris Toth, president of Oncology Systems, will present at the J.P. Morgan Healthcare Conference in San Francisco,...
Varian (NYSE: VAR) today announced its first quarter fiscal year 2020 earnings release date. The Company will report results for the first quarter of fiscal year 2020 after market close on...
Varian (NYSE: VAR) today announced that its Board of Directors has scheduled the 2020 Annual Meeting of Stockholders for February 13, 2020 with a record date of December 16, 2019. The meeting will...
According to the World Health Organization, the number of new cancer cases diagnosed per year in Africa is expected to grow from over 1 million in 2018 to over 2.1 million in 2040. Continuing its...
View all press releases
Teleconference: Access from within the U.S. by dialing 1-877-869-3847, and from outside the U.S. by dialing 1-201-689-8261. Replay: Access from within the U.S. by dialing 1-877-660-6853 and from...
View all events
Registration is required. Please email Katie Glenn at firstname.lastname@example.org by November 8, 2019.
View more events
Q4 FY19 Earnings Results
View all quarterly results
FY19 Annual Report
FY18 Sustainability Report
View all reports
VP, Treasurer and Investor Relations
1 650 424 6081
Varian Corporate Headquarters
3100 Hansen Way
Palo Alto, CA 94304-1038
Stay up to date on the latest investor information.